Stay updated on ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial
Sign up to get notified when there's something new on the ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial page.

Latest updates to the ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedBeta-thalassemia major keyword was added and the page revision updated to v3.4.2; the government funding lapse notice (revision v3.4.1) was removed.SummaryDifference0.5%

- Check20 days agoChange DetectedAdded a government funding lapse notice with guidance to check status at cc.nih.gov and opm.gov; updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedUI updates include a new Show glossary option, and label changes such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. Additionally, a new revision note 'Revision: v3.4.0' was added and the old labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4; no substantive changes to the study details or page content are evident.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a dedicated Locations section listing study sites in California, Georgia, Massachusetts, Minnesota, and Pennsylvania, and removed the prior California/Georgia/Massachusetts/Minnesota/Pennsylvania location blocks.SummaryDifference0.7%

- Check92 days agoChange DetectedPublications are now described as automatically filled from PubMed with a new Revision: v3.3.2, replacing the previous note and Revision: v3.2.0.SummaryDifference0.1%

Stay in the know with updates to ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial page.